{"id":380591,"date":"2020-11-13T01:03:19","date_gmt":"2020-11-13T06:03:19","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=380591"},"modified":"2020-11-13T01:03:19","modified_gmt":"2020-11-13T06:03:19","slug":"sanofi-selects-jeito-capital-as-its-first-investment-into-a-private-french-based-fund","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/sanofi-selects-jeito-capital-as-its-first-investment-into-a-private-french-based-fund\/","title":{"rendered":"Sanofi selects Jeito Capital as its first investment into a private French-based fund"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"center\" \/>\n<p align=\"center\">\n        <strong>Sanofi selects Jeito Capital as its first investment into a private French-based fund <\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong>Paris, France, 13 November 2020 \u2013 Jeito Capital (\u201cJeito\u201d),<\/strong> a rapidly emerging independent investor dedicated to biotech and biopharma, today announced that Sanofi has made a \u20ac50 million investment in Jeito Capital. The investment will be deployed by Jeito\u2019s highly experienced team of pharmaceutical and biotech experts in line with its investment criteria to provide an additional gateway for Sanofi to support French and European healthcare innovation. The coming together of a leader in industry with a leading investor will strengthen the ever-important healthcare eco-system and accelerate access to therapeutic innovation.<\/p>\n<p align=\"justify\">\n        <strong>Rafa\u00e8le Tordjman, Founder and CEO at Jeito, said:<\/strong><br \/>\n        <em>\u201cWe are delighted that Sanofi chose to become a major strategic investor in Jeito. Receiving such support from one of the global leaders in healthcare and France\u2019s largest R&amp;D investor underlines Jeito\u2019s commitment to improving healthcare in France and Europe. By bringing together industry and science and providing access to significant capital, Jeito is ideally positioned to deliver on its mission to improve healthcare for patients in France and beyond.\u201d <\/em>\n      <\/p>\n<p align=\"justify\">\n        <strong>Paul Hudson, CEO of Sanofi, said:<\/strong><br \/>\n        <em>\u201cWe are pleased to collaborate with Jeito Capital and its international team of pharma and biotech experts who are renowned for creating value through innovation. This investment provides Sanofi with access to the very best in French and European healthcare innovation and reinforces our commitment to investing in our medium and long-term development pipeline. We strongly believe in the potential of France and Europe to become a world-class hub for innovation in life sciences, which just needs the appropriate conditions and a stimulating environment in order to thrive.\u201d<\/em>\n      <\/p>\n<p align=\"justify\">Jeito\u2019s unique investment strategy is to provide long-term strategic support to new and established entrepreneurs, primarily in France and Europe, who are aspiring to help patients in need by pioneering novel, groundbreaking medicines that rethink traditional approaches. Leveraging their synergistic experience, Jeito\u2019s team provides continuity from clinical development to market access, especially in Europe and the Unites States, for breakthrough drugs with validated proofs of concept. This continuity is expressed both in the support provided to entrepreneurs by the Jeito team and by the investment of significant capital to ensure the growth of companies, the acceleration towards commercialization and faster access to these major innovations.<\/p>\n<p align=\"justify\">This investment is part of Sanofi\u2019s leading contribution to the development of an innovative healthcare eco-system in France and Europe. The company previously collaborated with Bpifrance to launch two public-private investment funds dedicated to French and European life sciences. Sanofi also stands as France\u2019s leading private R&amp;D investor, with more than \u20ac2 billion spent locally each year researching new treatments for patients, totaling half of the private research effort in France. Nearly 5,000 researchers and scientists work in a variety of therapeutic areas, mainly focusing on oncology, immuno-oncology, vaccines and rare diseases.<\/p>\n<p align=\"center\">\n        <strong>ENDS<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong>About Jeito Capital<\/strong><br \/>\n        <br \/>Jeito Capital is an international investment company with a patient benefit driven approach that focuses both on financing ground-breaking medical innovation and promoting positive societal impact. Jeito has a unique, long-term investment strategy, with the aim of providing continuity from clinical development to market access for breakthrough drugs with validated proofs of concept. This continuity is expressed both in the support provided to entrepreneurs by the Jeito Capital team and by the investment of significant capital to ensure the growth of companies, the acceleration towards commercialization and faster access to these major innovations.\u00a0 Jeito Capital is based in\u00a0Paris\u00a0with a presence in\u00a0Europe\u00a0and the United States. \u00a0<\/p>\n<p align=\"justify\">\n        <strong>About Sanofi<\/strong><br \/>\n        <br \/>Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, and provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions. With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.<\/p>\n<p>\n        <strong>For more information please contact:<\/strong>\n      <\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"vertical-align: top\">\n            <strong>Jeito Capital<\/strong><\/p>\n<p> Rafa\u00e8le Tordjman, Founder and CEO <\/p>\n<p><u>contact@jeito.life<\/u><\/p>\n<p><strong>Consilium Strategic Communications <\/strong><\/p>\n<p> Mary-Jane Elliott \/ Melissa Gardiner \/ Kris Lam<\/p>\n<p><a href=\"mailto:Jeito@consilium-comms.com\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>Jeito@consilium-comms.com<\/u><\/a><\/p>\n<p><strong>Ste<\/strong><strong>ele &amp; Holt (France)<\/strong><\/p>\n<p> Servane Tasl\u00e9\u00a0: <a href=\"mailto:servane@steeleandholt.com\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>servane@steeleandholt.com<\/u><\/a><\/p>\n<p> Ana\u00efs Miegeville : <a href=\"mailto:anais@steeleandholt.com\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>anais@steeleandholt.com<\/u><\/a><\/p>\n<p><strong>Sanofi<\/strong><\/p>\n<p> Chrystel Baude :\u00a0<a href=\"mailto:mr@sanofi.com\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>mr@sanofi.com<\/u><\/a><\/p>\n<p> \u00a0<\/td>\n<td style=\"vertical-align: top\">Tel: +33 6 35 36 35 00<\/p>\n<p> \u00a0<\/p>\n<p> \u00a0<\/p>\n<p> Tel: +44 (0) 20 3709 5700<\/p>\n<p> \u00a0<\/p>\n<p> \u00a0<\/p>\n<p> \u00a0<\/p>\n<p> Tel: +33 6 66 58 84 28<\/p>\n<p> Tel: +33 6 33 73 85 16<\/p>\n<p> \u00a0<\/p>\n<p> Tel: +33 1 53 77 46 46<\/td>\n<\/tr>\n<\/table>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQzNzkzNCM0MDA4MTc2NjcjNzAwMDEyMDc1\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Sanofi selects Jeito Capital as its first investment into a private French-based fund Paris, France, 13 November 2020 \u2013 Jeito Capital (\u201cJeito\u201d), a rapidly emerging independent investor dedicated to biotech and biopharma, today announced that Sanofi has made a \u20ac50 million investment in Jeito Capital. The investment will be deployed by Jeito\u2019s highly experienced team of pharmaceutical and biotech experts in line with its investment criteria to provide an additional gateway for Sanofi to support French and European healthcare innovation. The coming together of a leader in industry with a leading investor will strengthen the ever-important healthcare eco-system and accelerate access to therapeutic innovation. Rafa\u00e8le Tordjman, Founder and CEO at Jeito, said: \u201cWe are delighted that Sanofi chose to become &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/sanofi-selects-jeito-capital-as-its-first-investment-into-a-private-french-based-fund\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Sanofi selects Jeito Capital as its first investment into a private French-based fund&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-380591","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Sanofi selects Jeito Capital as its first investment into a private French-based fund - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/sanofi-selects-jeito-capital-as-its-first-investment-into-a-private-french-based-fund\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sanofi selects Jeito Capital as its first investment into a private French-based fund - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Sanofi selects Jeito Capital as its first investment into a private French-based fund Paris, France, 13 November 2020 \u2013 Jeito Capital (\u201cJeito\u201d), a rapidly emerging independent investor dedicated to biotech and biopharma, today announced that Sanofi has made a \u20ac50 million investment in Jeito Capital. The investment will be deployed by Jeito\u2019s highly experienced team of pharmaceutical and biotech experts in line with its investment criteria to provide an additional gateway for Sanofi to support French and European healthcare innovation. The coming together of a leader in industry with a leading investor will strengthen the ever-important healthcare eco-system and accelerate access to therapeutic innovation. Rafa\u00e8le Tordjman, Founder and CEO at Jeito, said: \u201cWe are delighted that Sanofi chose to become &hellip; Continue reading &quot;Sanofi selects Jeito Capital as its first investment into a private French-based fund&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/sanofi-selects-jeito-capital-as-its-first-investment-into-a-private-french-based-fund\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-13T06:03:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQzNzkzNCM0MDA4MTc2NjcjNzAwMDEyMDc1\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sanofi-selects-jeito-capital-as-its-first-investment-into-a-private-french-based-fund\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sanofi-selects-jeito-capital-as-its-first-investment-into-a-private-french-based-fund\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Sanofi selects Jeito Capital as its first investment into a private French-based fund\",\"datePublished\":\"2020-11-13T06:03:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sanofi-selects-jeito-capital-as-its-first-investment-into-a-private-french-based-fund\\\/\"},\"wordCount\":730,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sanofi-selects-jeito-capital-as-its-first-investment-into-a-private-french-based-fund\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDQzNzkzNCM0MDA4MTc2NjcjNzAwMDEyMDc1\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sanofi-selects-jeito-capital-as-its-first-investment-into-a-private-french-based-fund\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sanofi-selects-jeito-capital-as-its-first-investment-into-a-private-french-based-fund\\\/\",\"name\":\"Sanofi selects Jeito Capital as its first investment into a private French-based fund - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sanofi-selects-jeito-capital-as-its-first-investment-into-a-private-french-based-fund\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sanofi-selects-jeito-capital-as-its-first-investment-into-a-private-french-based-fund\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDQzNzkzNCM0MDA4MTc2NjcjNzAwMDEyMDc1\",\"datePublished\":\"2020-11-13T06:03:19+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sanofi-selects-jeito-capital-as-its-first-investment-into-a-private-french-based-fund\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sanofi-selects-jeito-capital-as-its-first-investment-into-a-private-french-based-fund\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sanofi-selects-jeito-capital-as-its-first-investment-into-a-private-french-based-fund\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDQzNzkzNCM0MDA4MTc2NjcjNzAwMDEyMDc1\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDQzNzkzNCM0MDA4MTc2NjcjNzAwMDEyMDc1\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sanofi-selects-jeito-capital-as-its-first-investment-into-a-private-french-based-fund\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sanofi selects Jeito Capital as its first investment into a private French-based fund\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sanofi selects Jeito Capital as its first investment into a private French-based fund - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/sanofi-selects-jeito-capital-as-its-first-investment-into-a-private-french-based-fund\/","og_locale":"en_US","og_type":"article","og_title":"Sanofi selects Jeito Capital as its first investment into a private French-based fund - Market Newsdesk","og_description":"Sanofi selects Jeito Capital as its first investment into a private French-based fund Paris, France, 13 November 2020 \u2013 Jeito Capital (\u201cJeito\u201d), a rapidly emerging independent investor dedicated to biotech and biopharma, today announced that Sanofi has made a \u20ac50 million investment in Jeito Capital. The investment will be deployed by Jeito\u2019s highly experienced team of pharmaceutical and biotech experts in line with its investment criteria to provide an additional gateway for Sanofi to support French and European healthcare innovation. The coming together of a leader in industry with a leading investor will strengthen the ever-important healthcare eco-system and accelerate access to therapeutic innovation. Rafa\u00e8le Tordjman, Founder and CEO at Jeito, said: \u201cWe are delighted that Sanofi chose to become &hellip; Continue reading \"Sanofi selects Jeito Capital as its first investment into a private French-based fund\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/sanofi-selects-jeito-capital-as-its-first-investment-into-a-private-french-based-fund\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-13T06:03:19+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQzNzkzNCM0MDA4MTc2NjcjNzAwMDEyMDc1","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sanofi-selects-jeito-capital-as-its-first-investment-into-a-private-french-based-fund\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sanofi-selects-jeito-capital-as-its-first-investment-into-a-private-french-based-fund\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Sanofi selects Jeito Capital as its first investment into a private French-based fund","datePublished":"2020-11-13T06:03:19+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sanofi-selects-jeito-capital-as-its-first-investment-into-a-private-french-based-fund\/"},"wordCount":730,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sanofi-selects-jeito-capital-as-its-first-investment-into-a-private-french-based-fund\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQzNzkzNCM0MDA4MTc2NjcjNzAwMDEyMDc1","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sanofi-selects-jeito-capital-as-its-first-investment-into-a-private-french-based-fund\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/sanofi-selects-jeito-capital-as-its-first-investment-into-a-private-french-based-fund\/","name":"Sanofi selects Jeito Capital as its first investment into a private French-based fund - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sanofi-selects-jeito-capital-as-its-first-investment-into-a-private-french-based-fund\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sanofi-selects-jeito-capital-as-its-first-investment-into-a-private-french-based-fund\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQzNzkzNCM0MDA4MTc2NjcjNzAwMDEyMDc1","datePublished":"2020-11-13T06:03:19+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sanofi-selects-jeito-capital-as-its-first-investment-into-a-private-french-based-fund\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/sanofi-selects-jeito-capital-as-its-first-investment-into-a-private-french-based-fund\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sanofi-selects-jeito-capital-as-its-first-investment-into-a-private-french-based-fund\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQzNzkzNCM0MDA4MTc2NjcjNzAwMDEyMDc1","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQzNzkzNCM0MDA4MTc2NjcjNzAwMDEyMDc1"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sanofi-selects-jeito-capital-as-its-first-investment-into-a-private-french-based-fund\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Sanofi selects Jeito Capital as its first investment into a private French-based fund"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/380591","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=380591"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/380591\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=380591"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=380591"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=380591"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}